Development of docetaxel-loaded (Soluplus®-PF108) mixed micelles vacuum foam-dried product for improved stability and melanoma treatment by QbD approach
Abstract Background Docetaxel (DTX) finds extensive use in treating various cancers, but its limited solubility, side effects, and multi-drug resistance (MDR) hinder its effectiveness. To enhance DTX's properties, the study aimed to formulate DTX-loaded mixed micelles (MMs) and evaluate their a...
Saved in:
Main Authors: | Rutuja Chougale (Author), Kiran Patil (Author), John Disouza (Author), Ashok Hajare (Author), Namdeo Jadhav (Author), Popat Kumbhar (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statistically developed docetaxel-laden mixed micelles for improved therapy of breast cancer
by: Smita S. Patil, et al.
Published: (2022) -
Design, development, and evaluation of docetaxel-loaded niosomes for the treatment of breast cancer
by: Dipika S. Gaikwad, et al.
Published: (2023) -
Applications of quality by design (QbD) and its tools in drug delivery
by: Lan Zhang, et al.
Published: (2016) -
QbD approach to HPLC method development and validation of ceftriaxone sodium
by: Krunal Y. Patel, et al.
Published: (2021) -
Ensuring Pharmaceutical Product Success through Excipient QbD Efforts
by: Mohammad Siddique Qadir
Published: (2022)